ANF includes 11 more companies in ephedrine case investigation

Published
0

ANF includes 11 more companies in ephedrine case investigation
Ali Musa Gilani. — File Photo

ISLAMABAD: The Anti-Narcotics Force (ANF) on Tuesday included 11 more pharmaceutical companies in its investigation of the ephedrine quota case, DawnNews reported.

Moreover, the ANF also summoned the owners of these companies. Sources in the ANF told DawnNews that summon notices for April 25 and 26 had been sent to the companies’ owners.

Sources moreover said that a quota of 6,000 kilograms of ephedrine was granted to the companies which exceeded the legal limit.

Earlier on April 19, the ANF had submitted a report before the Supreme Court formally naming eight accused, including Prime Minister’s Yousuf Raza Gilani’s son Ali Musa Gilani, for their alleged involvement in the scam.

However, Musa Gilani has denied involvement and has said that he is being wrongly implicated.

Moreover, during repeated media interactions, Prime Minister Gilani has indirectly been warning officials against implicating his son in the case.

Opinion

Editorial

Prudent warning
Updated 25 Oct, 2026

Prudent warning

Muslim countries have warned against a new conflict. But will the war lobbies in Washington and Tel Aviv listen?
Party of one
25 Oct, 2026

Party of one

IT ill behoves a political party that claims to be the biggest and most popular in the country to be so mired in...
Reckless driving
25 Oct, 2026

Reckless driving

THERE is a lack of official data documenting the crisis, but even by the most conservative estimates, over a dozen...
Breaking the cycle
Updated 24 Oct, 2026

Breaking the cycle

Workers’ remittances have helped the current account and rebuilt reserves, and continued external borrowing has bought time.
Gaza starvation
24 Oct, 2026

Gaza starvation

ON account of funding cuts and Israeli cruelty, the threat of famine once again looms over the occupied Gaza Strip....
Harvesting rackets
24 Oct, 2026

Harvesting rackets

ORGAN vending rarely leaves the spotlight. The FIA and the Human Organ Transplantation Authority recently took five...